全文获取类型
收费全文 | 2183篇 |
免费 | 159篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 91篇 |
妇产科学 | 32篇 |
基础医学 | 185篇 |
口腔科学 | 69篇 |
临床医学 | 317篇 |
内科学 | 646篇 |
皮肤病学 | 36篇 |
神经病学 | 51篇 |
特种医学 | 263篇 |
外科学 | 298篇 |
综合类 | 57篇 |
一般理论 | 5篇 |
预防医学 | 116篇 |
眼科学 | 30篇 |
药学 | 115篇 |
中国医学 | 2篇 |
肿瘤学 | 84篇 |
出版年
2015年 | 26篇 |
2014年 | 29篇 |
2013年 | 57篇 |
2012年 | 47篇 |
2011年 | 65篇 |
2010年 | 41篇 |
2009年 | 49篇 |
2008年 | 64篇 |
2007年 | 87篇 |
2006年 | 41篇 |
2005年 | 65篇 |
2004年 | 61篇 |
2003年 | 36篇 |
2002年 | 44篇 |
2001年 | 42篇 |
2000年 | 35篇 |
1999年 | 44篇 |
1998年 | 59篇 |
1997年 | 38篇 |
1996年 | 65篇 |
1995年 | 56篇 |
1994年 | 47篇 |
1993年 | 59篇 |
1992年 | 40篇 |
1991年 | 48篇 |
1990年 | 46篇 |
1989年 | 48篇 |
1988年 | 70篇 |
1987年 | 63篇 |
1986年 | 49篇 |
1985年 | 58篇 |
1984年 | 34篇 |
1983年 | 31篇 |
1982年 | 28篇 |
1981年 | 42篇 |
1980年 | 43篇 |
1979年 | 50篇 |
1978年 | 40篇 |
1977年 | 40篇 |
1976年 | 28篇 |
1975年 | 36篇 |
1974年 | 35篇 |
1973年 | 42篇 |
1972年 | 29篇 |
1971年 | 34篇 |
1970年 | 25篇 |
1969年 | 34篇 |
1968年 | 37篇 |
1967年 | 25篇 |
1966年 | 27篇 |
排序方式: 共有2401条查询结果,搜索用时 78 毫秒
1.
2.
3.
4.
Other techniques for cast preparation have been described.1–4 However, the techniques for trimming unmounted and mounted casts described in this article (1) allow fabrication of casts which fulfill the needs of most practicing dentists, (2) offer accuracy for examination, treatment planning, and consultation, and (3) offer professionally appealing dental casts. Only standard and commonly used dental materials and instruments are necessary. Criteria are defined which aid in evaluation of completed casts. 相似文献
5.
Keith H. Sherwood DDSa James G. Burch DDS MSb William J. Thompson DDS MSb 《American journal of orthodontics and dentofacial orthopedics》2002,122(6):593-600
The intent of this study was threefold: (1) to validate true intrusion of molars in adults, (2) to test the stability of miniplates as anchorage for intruding posterior teeth in the maxilla, and (3) to record the skeletal and dental changes of open-bite closure. Four adult patients who had anterior open-bite malocclusions were selected to undergo posterior intrusion with miniplate anchorage to close the open bite; all had true intrusion of the maxillary molars. Mean molar intrusion was 1.99 mm (range, 1.45-3.32 mm). No movement of miniplates occurred at any time during their use or before intentional clinical removal. Open-bite closure was achieved for all 4 patients. Mean closure of incisors was 3.62 mm (range, 3.0-4.5 mm) as the mandibular plane closed 2.62 degrees (range, 1.5 degrees -4.5 degrees ), and the occlusal plane decreased 2.25 degrees (range, 1.0 degrees -3.5 degrees ). Anterior facial heights decreased as the mandible closed and B-point rotated anteriorly and upward. 相似文献
6.
7.
清开灵与利巴韦林治疗小儿呼吸道合胞病毒肺炎的比较:单盲、随机、平行对照试验 总被引:1,自引:0,他引:1
目的:比较清开灵与利巴韦林对呼吸道合胞病毒肺炎患儿治疗效果的差异。方法:选择2005-02/2006-04在北京儿童医院分中心治疗的小儿呼吸道合胞病毒肺炎97例,患儿法定监护人知情同意。采用单盲、随机、平行对照试验的原则,按区组随机化方法分为2组,清开灵注射液组49例,利巴韦林组48例。①清开灵注射液组:清开灵注射液静脉滴注加口服中成药。②利巴韦林组:利巴韦林注射液静脉滴注加口服复方愈创木酚磺酸钾口服液。两组疗程均为10d,比较两组患儿的疗效。结果:清开灵注射液组脱落3例,利巴韦林组脱落1例,进入结果分析清开灵注射液组46例,利巴韦林组47例。①清开灵注射液组发热患儿体温恢复正常时间比利巴韦林组短[(2.72±1.86)d,(6.29±2.41)d(P<0.01)]。②清开灵注射液组患儿咳嗽、痰壅、气促症状积分改善方面优于利巴韦林组(P<0.05~0.01)。③清开灵注射液组的呼吸道合胞病毒转阴时间明显优于利巴韦林组。④咳嗽、痰壅、病毒转阴时间、气促均进入Logistic模型,其中前两个症状的回归系数绝对值较大。结论:清开灵注射液治疗小儿呼吸道合胞病毒肺炎在退热、止咳平喘、呼吸道合胞病毒转阴时间等方面均具有明显优势,咳嗽、痰壅这两个症状更能反映清开灵注射液的疗效优于利巴韦林。 相似文献
8.
Smith T Blumenthal H Diamond M Mauskop A Ames M McDonald S Lener S Burch S 《Headache》2007,47(5):683-692
OBJECTIVE: To describe the pain relief, satisfaction, and health-related quality of life results of moderate or severe migraines treated with a sumatriptan/naproxen sodium combination tablet. METHODS: Sumatriptan and naproxen sodium as a single-dose formulation tablet was used to treat moderate to severe migraines over a 12-month period in a phase 3, open-label, multicenter study (n = 565) in patients with at least 6 months' history of migraine headaches. RESULTS: Seventy percent of all attacks were treated with 1 dose of sumatriptan/naproxen sodium. Overall subjects treated 24,485 attacks; of these, 81% attacks achieved pain relief and 60% pain-free by 2 hours. At 3 months, the percentage of patients satisfied or very satisfied increased from baseline on all 8 Patient Perception of Migraine Questionnaire (PPMQ) items and remained high throughout the study. Mean Migraine-Specific Quality of Life Questionnaire (MSQ) domain scores also increased by 13-15 points from baseline during this time and remained high. CONCLUSIONS: Sumatriptan/naproxen sodium provides consistent relief of migraine attacks over 12 months, resulting in improved patient satisfaction and migraine specific quality of life. 相似文献
9.
The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview 总被引:1,自引:0,他引:1
10.
HJ Alter ; GE Tegtmeier ; BW Jett ; S Quan ; JW Shih ; WL Bayer ; A Polito 《Transfusion》1991,31(8):771-776
Samples from prospectively followed recipients, their respective donors, and a cohort of random donors were used to evaluate the specificity and efficacy of a recombinant immunoblot assay (RIBA) as an adjunct to anti-hepatitis C virus (HCV) testing by enzyme immunoassay (EIA). RIBA reacted (RIBA+) in 100 percent of patients who developed hepatitis associated with anti-HCV seroconversion documented by EIA and in 100 percent of the EIA-positive (EIA+) donors implicated in these cases. In contrast, RIBA reacted in none of 10 recipients who were EIA+ but did not develop hepatitis, in none of 7 EIA+ patients with hepatitis B or cytomegalovirus infection, in 33 percent of EIA+ donors who were not implicated in hepatitis transmission, and in 37 percent of EIA+ random donors. Hence, the vast majority of EIA+ individuals who have ancillary evidence of HCV infection react on RIBA, whereas the majority of EIA+ individuals in low-risk settings do not react (RIBA-negative, or RIBA-). There was a strong association between RIBA reactivity and the presence of a surrogate marker (elevated alanine aminotransferase [ALT] and/or antibody to hepatitis B core antigen); 43 percent of RIBA+ implicated donors had a surrogate marker as compared to none of 14 EIA+, RIBA- donors. Among EIA+ random donors, 77 percent of those with a surrogate marker were RIBA+, as compared with 29 percent of those without a surrogate marker. In addition, in EIA+ donors, RIBA reactivity correlated with the extent of ALT elevation; 86 percent of those with an ALT greater than 135 IU per L were RIBA+ compared with 18 percent of those with an ALT less than 30 IU per L.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献